tiprankstipranks
Trending News
More News >
Insmed (INSM)
NASDAQ:INSM

Compare Insmed (INSM) vs. Competitors

Compare
1,042 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Insmed
$176.00
$37.34B
-28.47
166.22%
16 Buy
1 Hold
0 Sell
Strong Buy
BioMarin Pharmaceutical
$61.31
$11.54B
22.97
-9.71%
14 Buy
5 Hold
0 Sell
Moderate Buy
Incyte
$110.57
$20.94B
18.55
51.07%
9 Buy
9 Hold
1 Sell
Moderate Buy
Genmab
$33.90
$20.36B
14.28
52.84%
5 Buy
2 Hold
0 Sell
Moderate Buy
BioNTech SE
$100.08
$23.59B
-38.04
-21.12%
12 Buy
3 Hold
0 Sell
Strong Buy
Royalty Pharma
$41.39
$23.47B
23.24
58.95%
3 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
INSM
Insmed
176.00
110.75
169.73%
BMRN
BioMarin Pharmaceutical
61.31
-6.07
-9.01%
INCY
Incyte
110.57
40.03
56.75%
GMAB
Genmab
33.90
11.75
53.05%
BNTX
BioNTech SE
100.08
-22.77
-18.53%
RPRX
Royalty Pharma
41.39
12.63
43.92%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts